ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 169 filers reported holding ANIKA THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $206,000 | -62.9% | 5,737 | -56.0% | 0.00% | -100.0% |
| Q3 2021 | $555,000 | 0.0% | 13,030 | +1.7% | 0.00% | 0.0% |
| Q2 2021 | $555,000 | +0.2% | 12,810 | -5.6% | 0.00% | 0.0% |
| Q1 2021 | $554,000 | +16.6% | 13,575 | +29.3% | 0.00% | 0.0% |
| Q4 2020 | $475,000 | +43.1% | 10,500 | +12.0% | 0.00% | 0.0% |
| Q3 2020 | $332,000 | -7.0% | 9,374 | -1.0% | 0.00% | 0.0% |
| Q2 2020 | $357,000 | -17.2% | 9,466 | -36.6% | 0.00% | 0.0% |
| Q1 2020 | $431,000 | -42.7% | 14,920 | +2.9% | 0.00% | -50.0% |
| Q4 2019 | $752,000 | -2.0% | 14,495 | +3.7% | 0.00% | 0.0% |
| Q3 2019 | $767,000 | +34.6% | 13,973 | -0.5% | 0.00% | +100.0% |
| Q2 2019 | $570,000 | +32.9% | 14,040 | -1.0% | 0.00% | 0.0% |
| Q1 2019 | $429,000 | +97.7% | 14,179 | +120.0% | 0.00% | 0.0% |
| Q4 2018 | $217,000 | -20.2% | 6,446 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $272,000 | +32.0% | 6,446 | 0.0% | 0.00% | – |
| Q2 2018 | $206,000 | -41.8% | 6,446 | -9.5% | 0.00% | -100.0% |
| Q1 2018 | $354,000 | -12.4% | 7,126 | -5.0% | 0.00% | 0.0% |
| Q4 2017 | $404,000 | -7.1% | 7,499 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $435,000 | +17.6% | 7,499 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $370,000 | -50.6% | 7,499 | -56.5% | 0.00% | -50.0% |
| Q1 2017 | $749,000 | -11.4% | 17,250 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $845,000 | +144.2% | 17,250 | +138.5% | 0.00% | +100.0% |
| Q3 2016 | $346,000 | -10.8% | 7,232 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $388,000 | +20.1% | 7,232 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $323,000 | +17.0% | 7,232 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $276,000 | +20.0% | 7,232 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $230,000 | -25.3% | 7,232 | -22.4% | 0.00% | 0.0% |
| Q2 2015 | $308,000 | -19.8% | 9,319 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $384,000 | +1.1% | 9,319 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $380,000 | +11.1% | 9,319 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $342,000 | -30.2% | 9,319 | -11.9% | 0.00% | 0.0% |
| Q2 2014 | $490,000 | -18.3% | 10,578 | -27.6% | 0.00% | 0.0% |
| Q1 2014 | $600,000 | +7.7% | 14,606 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $557,000 | +59.1% | 14,606 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $350,000 | +41.1% | 14,606 | 0.0% | 0.00% | 0.0% |
| Q2 2013 | $248,000 | – | 14,606 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Technologies Management, LLC | 44,875 | $2,031,000 | 2.14% |
| Parian Global Management LP | 102,705 | $4,648,000 | 1.16% |
| CAPITAL MANAGEMENT CORP /VA | 93,035 | $4,211,000 | 1.15% |
| Avidity Partners Management LP | 731,000 | $33,085,000 | 1.07% |
| Sio Capital Management, LLC | 65,382 | $2,959,000 | 0.61% |
| DIKER MANAGEMENT LLC | 21,835 | $988,000 | 0.50% |
| Archon Capital Management LLC | 48,925 | $2,214,000 | 0.38% |
| Caption Management, LLC | 362,800 | $16,420,000 | 0.37% |
| KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | 1,546,260 | $69,984,000 | 0.20% |
| Boston Trust Walden Corp | 378,167 | $17,116,000 | 0.18% |